Obesity and Overweight
Metabolic·MeSH: Overweight
Prevalence
42000.0 / 100K
Incidence
2000.0 / 100K/yr
10 drugs in development·4 companies·8 clinical trials
Drug Pipeline by Phase
Phase 3(1)
| Drug | Company |
|---|---|
| MET097 | PFIZER INC (PFE) |
Phase 2(3)
Phase 1(2)
Preclinical(2)
Phase 1/Phase 2(2)
| Drug | Company |
|---|---|
| met097 | PFIZER INC (PFE) |
| met233 | PFIZER INC (PFE) |
Compare drugs
Frequently asked questions
How many drugs are in development for Obesity and Overweight?
BioSniper tracks 10 drugs in development for Obesity and Overweight across 4 companies.
How many clinical trials target Obesity and Overweight?
There are 8 clinical trials targeting Obesity and Overweight tracked by BioSniper.
What is the prevalence of Obesity and Overweight?
The estimated prevalence of Obesity and Overweight is approximately 42000.0 per 100,000 population.
Deep-dive into Obesity and Overweight
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis